Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Ashish Kumar Kakkar"'
Autor:
Avaneesh Kumar Pandey, Nusrat Shafiq, Ashish Kumar Kakkar, Samir Malhotra, Beth Woods, Christopher Little, Tom Rhodes, Harriet Tuson, Zeshan Riaz, Tom Ashfield, Michael Corley, Ioannis Baltas
Publikováno v:
Communications Medicine, Vol 4, Iss 1, Pp 1-5 (2024)
Despite the constant development of antimicrobial resistance (AMR), few new antimicrobials are currently becoming available clinically. Alternative approaches, such as different mechanisms to fund their use, are being explored to encourage developmen
Externí odkaz:
https://doaj.org/article/c986fb808f0d49d4877a19b668d7566f
Autor:
Ashish Kumar Kakkar, Nusrat Shafiq
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
Externí odkaz:
https://doaj.org/article/04d8baf4798c4a54a27e4ae4281793d3
Autor:
Rubina Mulchandani, Tanica Lyngdoh, Sheetal Gandotra, H. S. Isser, Rajinder K. Dhamija, Ashish Kumar Kakkar
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
The coronavirus pandemic that began in December 2019, has had an unprecedented impact on the global economy, health systems and infrastructure, in addition to being responsible for significant mortality and morbidity worldwide. The “new normal” h
Externí odkaz:
https://doaj.org/article/80599ac0e23c4a0fa22e08f3773da629
Autor:
Suparna Chatterjee, Avijit Hazra, Raja Chakraverty, Nusrat Shafiq, Ashish Pathak, Niyati Trivedi, Balakrishnan Sadasivam, Ashish Kumar Kakkar, Ratinder Jhaj, Rajni Kaul, Nilima Kshirsagar
Publikováno v:
Perspectives in Clinical Research, Vol 13, Iss 2, Pp 99-105 (2022)
Purpose: This multicentric questionnaire-based study was undertaken to address the lack of systematic background data on the knowledge, attitudes, and practices among Indian physicians related to antimicrobial use and resistance. Materials and Method
Externí odkaz:
https://doaj.org/article/554b725f4a5e4fe7a3e4e5e4e16f2f2e
Autor:
Ashish Kumar Kakkar, Nusrat Shafiq, Gurpreet Singh, Pallab Ray, Vikas Gautam, Ritesh Agarwal, Jayashree Muralidharan, Pankaj Arora
Publikováno v:
Frontiers in Public Health, Vol 8 (2020)
World Health Organization (WHO) has identified antimicrobial resistance as one of the top 10 threats to public health. The agency has formulated a global action plan to tackle antimicrobial resistance by reducing incidence of infectious diseases, inc
Externí odkaz:
https://doaj.org/article/13f908b2f8a74952a51de63ebac3e6d5
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 22, Iss 1 (2019)
Purpose: Numerous studies across multiple specialties have evaluated the impact of trial registration on quality of study reports and found significant improvements over several domains. However, the impact of mandatory trial registration on the qual
Externí odkaz:
https://doaj.org/article/12adbad2b2f34b85af1a8704e74cc2a2
Autor:
Ashish Kumar Kakkar, Nusrat Shafiq, Neeru Sahni, Ritin Mohindra, Navjot Kaur, Nanda Gamad, Aditi Panditrao, Dimple Kondal, Samir Malhotra, Praveen Kumar M, Rachna Rohilla, Samiksha Bhattacharjee, Ankit Kumar, Ritika Kondel Bhandari, Avaneesh Kumar Pandey, Imraan Rather, Chakrant Mothsara, Cvn Harish, Devaraj Belavagi, Gopal Vishwas
Publikováno v:
Antibiotics, Vol 10, Iss 2, p 200 (2021)
Inappropriate antimicrobial prescribing is considered to be the leading cause of high burden of antimicrobial resistance (AMR) in resource-constrained lower- and middle-income countries. Under its global action plan, the World Health Organization has
Externí odkaz:
https://doaj.org/article/8622ddde8b2b44ff838704c5905b3a48
Autor:
Neha Dahiya, Ashish Kumar Kakkar
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 5, Iss 1, Pp 192-193 (2016)
Externí odkaz:
https://doaj.org/article/b74227566caf4945bda751c73db6c73e
Publikováno v:
Expert Review of Clinical Pharmacology. 16:39-47
Recent evidence has linked long-term use of angiotensin converting enzyme (ACE) inhibitors with the risk of developing lung cancer by increasing levels of substance P (SP) and bradykinin in lung tissue. DPP-4 inhibitors, by virtue of their mechanism
Publikováno v:
British Journal of Clinical Pharmacology. 89:556-560